Literature DB >> 19063880

Isobolographic analysis of interactions between 1-methyl-1,2,3,4-tetrahydroisoquinoline and four conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model.

Jarogniew J Luszczki1, Lucyna Antkiewicz-Michaluk, Stanislaw J Czuczwar.   

Abstract

The anticonvulsant activity of 1-methyl-1,2,3,4-tetrahydroisoquinoline (MeTHIQ--an endogenous parkinsonism-preventing substance) administered alone and in combination with four conventional antiepileptic drugs (carbamazepine, phenytoin, phenobarbital and valproate) was determined in the mouse maximal electroshock-induced seizure model. The types of interactions of MeTHIQ with the antiepileptic drugs were characterized using isobolographic analysis. The isobolographic analysis revealed that the combination of MeTHIQ with phenobarbital at the fixed-ratios of 1:3, 1:1 and 3:1 exerted supra-additive (synergistic) interaction in the maximal electroshock-induced seizure test. In contrast, the combinations of MeTHIQ with carbamazepine, phenytoin and valproate exerted additive interaction for all three fixed-ratios (1:3, 1:1 and 3:1) tested in the maximal electroshock-induced seizure test. In conclusion, MeTHIQ produces a clear-cut anticonvulsant effect in the maximal electroshock-induced seizure test in mice. The supra-additive interaction of MeTHIQ with phenobarbital against maximal electroshock-induced seizures makes their combination of pivotal importance from a clinical viewpoint.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19063880     DOI: 10.1016/j.ejphar.2008.11.049

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

1.  Effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline on the protective action of various antiepileptic drugs in the maximal electroshock-induced seizure model: a type II isobolographic analysis.

Authors:  Marta Andres-Mach; Anna Zadrożniak; Agnieszka Haratym-Maj; Magdalena Florek-Luszczki; Grzegorz Raszewski; Lucyna Antkiewicz-Michaluk; Jarogniew J Luszczki
Journal:  J Neural Transm (Vienna)       Date:  2013-06-07       Impact factor: 3.575

2.  Modafinil and its metabolites enhance the anticonvulsant action of classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model.

Authors:  Dorota Zolkowska; Marta Andres-Mach; Thomas E Prisinzano; Michael H Baumann; Jarogniew J Luszczki
Journal:  Psychopharmacology (Berl)       Date:  2015-02-21       Impact factor: 4.530

3.  Effect of Nobiletin on Experimental Model of Epilepsy.

Authors:  Baowang Yang; Jing Wang; Ni Zhang
Journal:  Transl Neurosci       Date:  2018-12-31       Impact factor: 1.757

4.  Influence of dronedarone (a class III antiarrhythmic drug) on the anticonvulsant potency of four classical antiepileptic drugs in the tonic-clonic seizure model in mice.

Authors:  Katarzyna M Sawicka; Agnieszka Wawryniuk; Jadwiga Daniluk; Sławomir Karwan; Magdalena Florek-Łuszczki; Jarosław Chmielewski; Jarogniew J Łuszczki
Journal:  J Neural Transm (Vienna)       Date:  2018-12-08       Impact factor: 3.575

5.  Influence of Umbelliferone on the Anticonvulsant and Neuroprotective Activity of Selected Antiepileptic Drugs: An In Vivo and In Vitro Study.

Authors:  Mirosław Zagaja; Anna Zagaja; Joanna Szala-Rycaj; Aleksandra Szewczyk; Marta Kinga Lemieszek; Grzegorz Raszewski; Marta Andres-Mach
Journal:  Int J Mol Sci       Date:  2022-03-23       Impact factor: 5.923

6.  Effects of WIN 55,212-2 (a non-selective cannabinoid CB1 and CB 2 receptor agonist) on the protective action of various classical antiepileptic drugs in the mouse 6 Hz psychomotor seizure model.

Authors:  Magdalena Florek-Luszczki; Aleksandra Wlaz; Maria W Kondrat-Wrobel; Piotr Tutka; Jarogniew J Luszczki
Journal:  J Neural Transm (Vienna)       Date:  2014-02-19       Impact factor: 3.575

7.  Effects of arachidonyl-2'-chloroethylamide (ACEA) on the protective action of various antiepileptic drugs in the 6-Hz corneal stimulation model in mice.

Authors:  Jarogniew J Luszczki; Pawel Patrzylas; Miroslaw Zagaja; Marta Andres-Mach; Katarzyna Zaluska; Maria W Kondrat-Wrobel; Monika Szpringer; Jaroslaw Chmielewski; Magdalena Florek-Luszczki
Journal:  PLoS One       Date:  2017-08-31       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.